Gene · 5890
RAD51B: RAD51 paralog B
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RAD51B: RAD51 paralog B. Genes, record 5890. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5890
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15315 | DNA repair protein RAD51 homolog 2 | 384 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents20
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 14333 | O15315 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3667 | O15315 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3667 | O15315 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 14333 | O15315 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 8028 | O15315 | Espacenet |
| US 11597924 B2 | 2023-03-07 | 150 | O15315 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 71096 | O15315 | Espacenet |
| US 11400116 B2 | 2022-08-02 | 5699 | O15315 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 174067 | O15315 | Espacenet |
| US 10501513 B2 | 2019-12-10 | 8028 | O15315 | Espacenet |
1 to 10 of 20
See all 20 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,446
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RAD51B papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 56 | 2025 |
| P50CA116201 | Mayo Clinic Breast Cancer SPORE | 22 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 16 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 12 | 2025 |
| ZIACP010126 | Hormone-Related Cancers | 12 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 11 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 9 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 8 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
1 to 10 of 1,446Source NIH's project files
See all 1,446 nih grantsPapers1,861
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A dual gating mechanism controls target-strand cleavage in Cas12j: Implications for engineering efficient nickases. | Protein Sci | 2026 | 42742450 | PubTator, text mining | PubMed |
| Distinct functions of mammalian RAD51 paralogs in genome maintenance. | Biochem Soc Trans | 2026 | 42682019 | PubTator, text mining | PubMed |
| The lncRNA CTD-2566 J3.1 orchestrates oncogenic gene regulation via chromatin interactions in luminal breast cancer. | Int J Biol Macromol | 2026 | 42442572 | PubTator, text mining | PubMed |
| Real-world clinical outcomes, genetic testing patterns, and treatment patterns of patients with metastatic castration-resistant prostate cancer treated with olaparib monotherapy in the United States. | Urol Oncol | 2026 | 42431822 | PubTator, text mining | PubMed |
| New and emerging entities of uterine mesenchymal tumours in the era of molecular testing. | Pol J Pathol | 2026 | 42429422 | PubTator, text mining | PubMed |
| Investigating the shared genetic architecture between selective immunoglobulin A deficiency and autoimmune diseases. | Hum Genet | 2026 | 42329450 | PubTator, text mining | PubMed |
| Integrated transcriptomic and epigenomic profiling reveals conserved molecular subtypes across systemic autoimmune diseases. | Ann Rheum Dis | 2026 | 42218077 | PubTator, text mining | PubMed |
| Uterine Myxoid Inflammatory Myofibroblastic Sarcoma (MIMS) Harboring Pathogenic KRAS Mutations and Expressing ER, PR, and CD10. | Int J Gynecol Pathol | 2026 | 42206731 | PubTator, text mining | PubMed |
| Particulate Hexavalent Chromium Inhibits RAD51 Paralogs Necessary for RAD51 Filament Formation and Stabilization During Homologous Recombination Repair. | Occup Health (Auckl) | 2026 | 42169974 | PubTator, text mining | PubMed |
| Cancer mutations in RAD51 and its paralogues. | PLoS One | 2026 | 42133623 | PubTator, text mining | PubMed |
1 to 10 of 1,861
See all 1,861 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5890
GET https://conductscience.org/api/genes/v1/5890/patents